Price
$127.84-1.02%Social Signal Score
Analyst Ratings
23 analystsRevenue
$221.59M+1084.73%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Quentin S. Blackford
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 2,400
- Beta
- 1.40
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 2.20
Financials
Revenue
$221.59M+1084.7%Net Income
$-29.85MEBITDA
$-21.23MFree Cash Flow
$-11.54MEPS (diluted)
$-0.90Shares Outstanding (diluted)
33.10M+97.5%Operating Expenses
$146.24MCash & Debt
$560.72MReturn of Capital
$0.00Revenue by Segment (annual)
$747.14MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $747.14M | $-44.55M | $-1.39 |
| 2024 | $591.84M | $-113.29M | $-3.63 |
| 2023 | $492.68M | $-123.41M | $-4.04 |
| 2022 | $410.92M | $-116.16M | $-3.88 |
| 2021 | $322.82M | $-101.36M | $-3.46 |
| 2020 | $265.17M | $-43.83M | $-1.58 |
| 2019 | $214.55M | $-54.57M | $-2.16 |
| 2018 | $147.28M | $-50.38M | $-2.02 |
| 2017 | $99.13M | $-29.74M | $-1.30 |
| 2016 | $64.07M | $-20.90M | $-3.95 |
| 2015 | $36.14M | $-22.80M | $-1.54 |
| 2014 | $21.75M | $-15.83M | $-1.07 |
| 2013 | $15.37M | $-13.59M | $-10.69 |
Valuation
IRTChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
0-100.00%Social Signal Score
Mentions (17)
- Newsbusinesswire.com·10h ago·Negative
IRTC Investors Have Opportunity to Join iRhythm Holdings, Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $IRTC--IRTC Investors Have Opportunity to Join iRhythm Holdings, Inc. Fraud Investigation with SBS Law.
View source ↗ - Newsglobenewswire.com·16d ago·Negative
iRhythm Holdings to Participate in Upcoming Investor Conferences SAN FRANCISCO, Nov. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the following investor conferences.
View source ↗ - News (RSS)fool·16d ago·Positive
iRhythm (IRTC) Q3 2026 Earnings Call Transcript Zio AT softened as buyers waited on VitalConnect, yet margins surged.
View source ↗ - News (RSS)seekingalpha·16d ago·Neutral
IRhythm plans Zio MCT FDA filing in 2027 while raising 2026 revenue outlook to $890M-$895M
View source ↗ - News (RSS)seekingalpha·16d ago·Positive
iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·16d ago·Negative
What iRhythm Technologies (IRTC) Said on Its Q3 Earnings Call iRhythm Technologies NASDAQ: IRTC raised its 2026 revenue and profitability outlook after reporting third-quarter growth driven by its core Zio monitor business, even as demand for its Zio AT telemetry product fell short of expectations.
View source ↗ - Newsseekingalpha.com·16d ago·Positive
iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript iRhythm Holdings, Inc. (IRTC) Q3 2026 Earnings Call Transcript
View source ↗ - Newsglobenewswire.com·38d ago·Negative
iRhythm Holdings to Report Third Quarter 2026 Financial Results on November 5, 2026 SAN FRANCISCO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the third quarter 2026 after the close of trading on Thursday, November 5, 2026. The company's management team will host a corresponding conference cal…
View source ↗ - Newsglobenewswire.com·47d ago·Neutral
iRhythm Holdings Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Patient Data Is Exposed Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from a reported data breach at iRhythm Holdings, Inc.
View source ↗ - Newsglobenewswire.com·48d ago·Neutral
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care SAN FRANCISCO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC) today announced that it completed the previously announced acquisition of Vital Connect, Inc. ("VitalConnect"), a leader in wearable biosensor technology and ambulatory cardiac monitoring.
View source ↗ - Newsglobenewswire.com·51d ago·Neutral
iRhythm Provides Update on Cybersecurity Incident Previously Disclosed in June 2026 Following completion of the forensic investigation, company begins notifying impacted individuals Following completion of the forensic investigation, company begins notifying impacted individuals
View source ↗ - Newszacks.com·79d ago·Positive
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated? iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
View source ↗ - Newsglobenewswire.com·88d ago·Negative
iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference.
View source ↗ - Newsseekingalpha.com·93d ago·Negative
iRhythm: The Algorithmic Margin Inflection Changes The Story iRhythm Technologies is evolving from a cardiac patch producer to a comprehensive cardiac monitoring platform, leveraging software and workflow integration for a competitive advantage. Q2 2026 marked a financial inflection: 20.1% revenue growth, 72.8% gross margin, and adjusted EBITDA margin expansion to 19.3%, with raised full-year guidance and record free cash flow. The ZEUS platform's FDA clearance enables significant margin leverag
View source ↗ - Newszacks.com·100d ago·Neutral
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform IRTC's VitalConnect deal expands its cardiac monitoring reach across ambulatory, inpatient and hospital-to-home care while opening new growth opportunities.
View source ↗ - Newszacks.com·100d ago·Positive
Here's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newszacks.com·104d ago·Positive
iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised IRTC posts 20.1% revenue growth, margin expansion and a higher 2026 outlook while advancing innovation and its Vital Connect acquisition.
View source ↗
Earnings
Thu, Feb 18(in 3 months)
Consensus estimate $0.20 per share
Typical surprise +55.6% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Nov 5$0.82 vs $0.02beat
- Thu, Aug 6$-0.01 vs $-0.04beat
- Thu, Apr 30$-0.43 vs $-0.56beat
- Thu, Feb 19$0.17 vs $0.02beat
- Thu, Oct 30$-0.16 vs $-0.36beat
- Thu, Jul 31$-0.44 vs $-0.53beat
Estimates and results for IRTC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by IRTC officers and directors.
- Bought
- $57k
- Sold
- $24.2m
1 trade
56 trades
- Wilson Daniel G.sold
- Blackford Quentin S.sold
- Murphy Patrick Michaelsold
- Patterson Chadsold
- Shrishrimal Sumisold
- Turakhia Minangsold
- Smith Mervinsold
- Rodda Juliannesold
43 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Richard Blumenthalsenate · CT · disclosed Sep 12, 2025 (29d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 12, 2025 (29d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 12, 2025 (29d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 12, 2025 (29d later)Sell$1,001 - $15,000
- Richard Blumenthalsenate · CT · disclosed Sep 12, 2025 (29d later)Sell$1,001 - $15,000
- Donna Shalalahouse · FL27 · disclosed Apr 27, 2020 (308d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
